STAAR Surgical Appoints Andrew Pilon, OD, as Vice President of Business Development - VisionMonday.com
LAKE FOREST, Calif.—STAAR Surgical Co. (NASDAQ: STAA), a leader in phakic intraocular lenses (IOLs) with its EVO family of Implantable Collamer Lenses (EVO ICL), has appointed Andrew Pilon, OD, as vice president of business development, which is a new position, the company told VMAIL. Dr. Pilon will report to Warren Foust, STAAR’s president and CEO, and work closely with the company’s senior leadership team to capitalize on opportunities that support STAAR’s innovation strategy and expand its product portfolio, according to the announcement from the company. Dr. Pilon joins STAAR from Johnson & Johnson Vision, where he spent nearly six years as senior director of business development for the surgical vision division. In that role, he led efforts to evaluate and advance strategic partnerships, acquisitions and licensing opportunities across Johnson & Johnson’s global ophthalmology portfolio, the announcement noted. "Andrew brings a unique combination of clinical expertise, extensive ophthalmology experience, and a strong track record in strategic growth," said Foust.











